361 related articles for article (PubMed ID: 30563937)
21. MET oncogene inhibition as a potential target of therapy for uveal melanomas.
Abdel-Rahman MH; Boru G; Massengill J; Salem MM; Davidorf FH
Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3333-9. PubMed ID: 20164465
[TBL] [Abstract][Full Text] [Related]
22. Anti-invasive effects of celastrol in hypoxia-induced fibroblast-like synoviocyte through suppressing of HIF-1α/CXCR4 signaling pathway.
Li GQ; Liu D; Zhang Y; Qian YY; Zhu YD; Guo SY; Sunagawa M; Hisamitsu T; Liu YQ
Int Immunopharmacol; 2013 Dec; 17(4):1028-36. PubMed ID: 24144813
[TBL] [Abstract][Full Text] [Related]
23. HIF-1α stabilization by mitochondrial ROS promotes Met-dependent invasive growth and vasculogenic mimicry in melanoma cells.
Comito G; Calvani M; Giannoni E; Bianchini F; Calorini L; Torre E; Migliore C; Giordano S; Chiarugi P
Free Radic Biol Med; 2011 Aug; 51(4):893-904. PubMed ID: 21703345
[TBL] [Abstract][Full Text] [Related]
24. CXCR4 promotes the growth and metastasis of esophageal squamous cell carcinoma as a critical downstream mediator of HIF-1α.
Wu X; Zhang H; Sui Z; Gao Y; Gong L; Chen C; Ma Z; Tang P; Yu Z
Cancer Sci; 2022 Mar; 113(3):926-939. PubMed ID: 34990040
[TBL] [Abstract][Full Text] [Related]
25. PHA665752 inhibits the HGF-stimulated migration and invasion of cells by blocking PI3K/AKT pathway in uveal melanoma.
Wang Z; He C; Liu L; Ma N; Chen X; Zheng D; Qiu GH
Neoplasma; 2017; 64(3):377-388. PubMed ID: 28253717
[TBL] [Abstract][Full Text] [Related]
26. Menadione and ethacrynic acid inhibit the hypoxia-inducible factor (HIF) pathway by disrupting HIF-1α interaction with p300.
Na YR; Han KC; Park H; Yang EG
Biochem Biophys Res Commun; 2013 May; 434(4):879-84. PubMed ID: 23618863
[TBL] [Abstract][Full Text] [Related]
27. Association of TYRP1 with hypoxia and its correlation with patient outcome in uveal melanoma.
Jha J; Singh MK; Singh L; Pushker N; Lomi N; Meel R; Chosdol K; Sen S; Bakhshi S; Kashyap S
Clin Transl Oncol; 2021 Sep; 23(9):1874-1884. PubMed ID: 33811629
[TBL] [Abstract][Full Text] [Related]
28. Chemokine receptor CCR7 expression predicts poor outcome in uveal melanoma and relates to liver metastasis whereas expression of CXCR4 is not of clinical relevance.
van den Bosch T; Koopmans AE; Vaarwater J; van den Berg M; de Klein A; Verdijk RM
Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7354-61. PubMed ID: 24052640
[TBL] [Abstract][Full Text] [Related]
29. LincRNA-p21 promotes mesenchymal stem cell migration capacity and survival through hypoxic preconditioning.
Meng SS; Xu XP; Chang W; Lu ZH; Huang LL; Xu JY; Liu L; Qiu HB; Yang Y; Guo FM
Stem Cell Res Ther; 2018 Oct; 9(1):280. PubMed ID: 30359325
[TBL] [Abstract][Full Text] [Related]
30. Targeting Bcl-2/Bcl-XL induces antitumor activity in uveal melanoma patient-derived xenografts.
Némati F; de Montrion C; Lang G; Kraus-Berthier L; Carita G; Sastre-Garau X; Berniard A; Vallerand D; Geneste O; de Plater L; Pierré A; Lockhart B; Desjardins L; Piperno-Neumann S; Depil S; Decaudin D
PLoS One; 2014; 9(1):e80836. PubMed ID: 24454684
[TBL] [Abstract][Full Text] [Related]
31. Bevacizumab and intraocular tumors: an intriguing paradox.
el Filali M; Ly LV; Luyten GP; Versluis M; Grossniklaus HE; van der Velden PA; Jager MJ
Mol Vis; 2012; 18():2454-67. PubMed ID: 23077404
[TBL] [Abstract][Full Text] [Related]
32. The HIF-1α/CXCR4 pathway supports hypoxia-induced metastasis of human osteosarcoma cells.
Guan G; Zhang Y; Lu Y; Liu L; Shi D; Wen Y; Yang L; Ma Q; Liu T; Zhu X; Qiu X; Zhou Y
Cancer Lett; 2015 Feb; 357(1):254-264. PubMed ID: 25444927
[TBL] [Abstract][Full Text] [Related]
33. Hypoxia promotes migration and induces CXCR4 expression via HIF-1α activation in human osteosarcoma.
Guo M; Cai C; Zhao G; Qiu X; Zhao H; Ma Q; Tian L; Li X; Hu Y; Liao B; Ma B; Fan Q
PLoS One; 2014; 9(3):e90518. PubMed ID: 24618817
[TBL] [Abstract][Full Text] [Related]
34. Involvement of HIF-1 in invasion of Mum2B uveal melanoma cells.
Victor N; Ivy A; Jiang BH; Agani FH
Clin Exp Metastasis; 2006; 23(1):87-96. PubMed ID: 16826425
[TBL] [Abstract][Full Text] [Related]
35. Visualization of hypoxia-inducible factor 1α-p300 interactions in live cells by fluorescence resonance energy transfer.
Kim SY; Lee MJ; Na YR; Kim SY; Yang EG
J Cell Biochem; 2014 Feb; 115(2):271-80. PubMed ID: 23966271
[TBL] [Abstract][Full Text] [Related]
36. RNA interference targeting hypoxia-inducible factor 1α via a novel multifunctional surfactant attenuates glioma growth in an intracranial mouse model.
Gillespie DL; Aguirre MT; Ravichandran S; Leishman LL; Berrondo C; Gamboa JT; Wang L; King R; Wang X; Tan M; Malamas A; Lu ZR; Jensen RL
J Neurosurg; 2015 Feb; 122(2):331-41. PubMed ID: 25423275
[TBL] [Abstract][Full Text] [Related]
37. P2RX7-V3 is a novel oncogene that promotes tumorigenesis in uveal melanoma.
Pan H; Ni H; Zhang L; Xing Y; Fan J; Li P; Li T; Jia R; Ge S; Zhang H; Fan X
Tumour Biol; 2016 Oct; 37(10):13533-13543. PubMed ID: 27468714
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of chemokine receptor expression on uveal melanomas by CXCR4 siRNA and its effect on uveal melanoma liver metastases.
Li H; Yang W; Chen PW; Alizadeh H; Niederkorn JY
Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5522-8. PubMed ID: 19553629
[TBL] [Abstract][Full Text] [Related]
39. Paracrine Effect of NRG1 and HGF Drives Resistance to MEK Inhibitors in Metastatic Uveal Melanoma.
Cheng H; Terai M; Kageyama K; Ozaki S; McCue PA; Sato T; Aplin AE
Cancer Res; 2015 Jul; 75(13):2737-48. PubMed ID: 25952648
[TBL] [Abstract][Full Text] [Related]
40. Beta-blockers exert potent anti-tumor effects in cutaneous and uveal melanoma.
Bustamante P; Miyamoto D; Goyeneche A; de Alba Graue PG; Jin E; Tsering T; Dias AB; Burnier MN; Burnier JV
Cancer Med; 2019 Dec; 8(17):7265-7277. PubMed ID: 31588689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
